Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing
Patent
1999-07-22
2000-11-14
Slobodyansky, Elizabeth
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
435 4, 435183, 530350, A61K 3843, C12N 900, C12Q 125, C07K 1447
Patent
active
061466247
ABSTRACT:
The invention provides a human ubiquitin-conjugating enzyme (HUBI) and polynucleotides which identify and encode HUBI. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HUBI.
REFERENCES:
Verma, R. et al., "Phosphorylation of Siclp by G.sub.1 Cdk Required for Its Degradation and Entry into S Phase" Science (1997) 278:455-460.
Ciechanover, Aaron, "The Ubiquitin-Proteasome Proteolytic Pathway" Cell (1994) 79:13-21.
Jentsch, Stefan, "The Ubiquitin-Conjugating System," Annu.Rev.Genet. (1992) 26:179-207.
Monia, B.P. et al., "Gene Synthesis, Expression, and Processing of Human Ubiquitin Carboxyl Extension Proteins." J.Biol.Chem. (1989) 264:4093-4103.
van Nocker, S. et al., "The Arabidopsis Thaliana UBC7/13/14 Genes Encode a Family of Multiubiquitin Chain-forming E2 Enzymes." J.Biol.Chem. (1996) 271:12150-12158.
Llovera, M. et al., "Muscle Wasting Associated with Cancer Cachexia in Linked to an Important Activation of the ATP-Dependent Ubiquitin-Mediated Proteolysis" Int.J.Cancer (1995) 61:138-141.
Gregori, L. et al., "Ubiquitin-Mediated Degradative Pathway Degrades the Extracellular but not the Intracellular Form of Amyloid .beta.-Protein Precursor" Biochem.Biophys.Res.Commun. (1994) 203:1731-1738.
Grant, E.P. et al., "Rate of Antigen Degradation by the Ubiquitin-Proteasome Pathway Influences MHC Class I Presentation" J.Immunol. (155:3750-3758.
Kershaw, J., GI 1628097, GenBank Sequence Database (Accession U39318), National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland, 20894.
Kershaw, J., GI 1628091, GenBack Sequence Database (Accession U39318), National Center of Biotechnology Information, National Library of Medicine, Bethesda, Maryland, 20894.
Faye, G.R., GI 4257, GenBank Sequence Database (Accession U39318), National Center for Biotechnology Information, National Library of Medicine, Bethesda, Maryland, 20894.
Faye, G.R., GI 4256, GenBank Sequence Database (Accession U39318), National Center for Biotechnolgy Information, National Library of Medicine, Bethesda, Maryland, 20894.
Corley Neil C.
Hillman Jennifer L.
Lal Preeti
Incyte Pharmaceuticals Inc.
Murry Lynn E.
Slobodyansky Elizabeth
LandOfFree
Human ubiquitin-conjugating enzymes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human ubiquitin-conjugating enzymes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human ubiquitin-conjugating enzymes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2062281